PharmaLex Group, a provider of specialized services for the pharma, biotech and medtech industries worldwide, announced a merger with pharmasol, a global life sciences organization focused on pharmacovigilance IT and business support.
Founded in 2001 and with headquarters in Germany, pharmasol provides software and hosting on a subscription basis, as well as pharmacovigilance (PV) services. psiXchange is a state-of-the-art safety letter distribution platform with a highly diversified portfolio of customers spanning leading pharmaceutical and biotech companies and top 10 global CROs.
“The merger with PharmaLex enables us to expand our market reach and provide a deeper pool of strategic advisory and solution consulting expertise for our clients,” said pharmasol CEO and owner Torsten Adam. “Furthermore, the merger provides both organizations with greater depth in the fast-growing and highly competitive area of pharmacovigilance.”
“pharmasol is an excellent fit for PharmaLex, offering strong technical expertise in solving complex and innovative data strategy and governance challenges, a platform that supports full end-to-end business process automation, scalable services and a team with deep technical and PV expertise,” said PharmaLex CEO Dr. Thomas Dobmeyer. “The merger enables us to expand our capabilities with highly talented people and advanced technology, while increasing our technology-enabled smart services footprint with end-to-end business process automation services.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!